Avantor (NYSE:AVTR) Sees Strong Trading Volume

Shares of Avantor, Inc. (NYSE:AVTR) saw an uptick in trading volume on Wednesday . 3,982,120 shares traded hands during mid-day trading, a decline of 32% from the previous session’s volume of 5,863,820 shares.The stock last traded at $22.39 and had previously closed at $21.17.

Analysts Set New Price Targets

A number of research firms have weighed in on AVTR. Citigroup downgraded Avantor from a “buy” rating to a “neutral” rating and lowered their target price for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. Royal Bank of Canada increased their target price on Avantor from $30.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, July 15th. Robert W. Baird cut their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, April 29th. Deutsche Bank Aktiengesellschaft raised their price target on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, April 18th. Finally, Barclays lowered their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, June 28th. Five investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, Avantor currently has a consensus rating of “Moderate Buy” and a consensus target price of $25.93.

Avantor Trading Up 2.0 %

The company has a 50 day simple moving average of $22.38 and a 200 day simple moving average of $23.60. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. The company has a market capitalization of $15.50 billion, a PE ratio of 58.51, a price-to-earnings-growth ratio of 2.30 and a beta of 1.32.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.68 billion. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business’s revenue was down 5.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.29 earnings per share. Analysts anticipate that Avantor, Inc. will post 1 earnings per share for the current year.

Institutional Investors Weigh In On Avantor

A number of large investors have recently made changes to their positions in the stock. Bank of New York Mellon Corp grew its position in shares of Avantor by 1.6% in the second quarter. Bank of New York Mellon Corp now owns 2,325,329 shares of the company’s stock valued at $49,297,000 after purchasing an additional 35,497 shares in the last quarter. Van Lanschot Kempen Investment Management N.V. grew its position in Avantor by 16.7% in the second quarter. Van Lanschot Kempen Investment Management N.V. now owns 2,902,290 shares of the company’s stock worth $61,529,000 after acquiring an additional 416,342 shares during the period. Blue Trust Inc. grew its position in Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after acquiring an additional 1,391 shares during the period. Assenagon Asset Management S.A. grew its position in Avantor by 403.4% in the second quarter. Assenagon Asset Management S.A. now owns 133,515 shares of the company’s stock worth $2,831,000 after acquiring an additional 106,992 shares during the period. Finally, Swedbank AB grew its position in Avantor by 1.3% in the second quarter. Swedbank AB now owns 107,182 shares of the company’s stock worth $2,272,000 after acquiring an additional 1,327 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.